(IBDV) |
| 0 (0%) 10-10 13:36 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 22.41 |
| Resistance 1: | 22.27 |
| Pivot price: | 22.12 |
| Support 1: | 22.05 |
| Support 2: | 18.35 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 10 Sep 2025
IBDV-SSA, a novel molecular approach for the recovery of infectious bursal disease virus whole genomes from FTA cards - ASM Journals
Sun, 31 Aug 2025
Characterization and pathogenicity of very virulent IBDV - Frontiers
Sat, 16 Aug 2025
Transcriptomic analysis identifies key genes associated with nutrient deprivation responses in infectious bursal disease virus infection - BMC Genomics
Fri, 08 Aug 2025
Winterfield 2512 G-61 Strain of IBDV Vaccine (CEVAC IBD L) Showed Reduced - researchgate.net
Thu, 19 Dec 2024
Serum metabolic alterations in chickens upon infectious bursal disease virus infection - BMC Veterinary Research
Fri, 06 Dec 2024
New approaches required to manage IBD in poultry - aviNews
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
